Comparison of serial S-100 and NSE serum measurements after severe head injury - PubMed (original) (raw)
Comparative Study
. 1997;139(12):1161-4; discussion 1165.
doi: 10.1007/BF01410977.
Affiliations
- PMID: 9479423
- DOI: 10.1007/BF01410977
Comparative Study
Comparison of serial S-100 and NSE serum measurements after severe head injury
C Woertgen et al. Acta Neurochir (Wien). 1997.
Abstract
We investigated the time course of neuron specific enolase (NSE) and S-100 protein after severe head injury in correlation to outcome. We included 30 patients (GCS < 9), who had been admitted within 5 hours after injury, in a prospective study. Blood samples were taken on admission, 6, 12, and 24 hours and every 24 hours up to the fifth day after injury. The outcome was estimated on discharge using the Glasgow Outcome Scale. 70% reached a good outcome. All concentrations of NSE and 83% of the S-100 samples were elevated concerning the first probe (30.2 micrograms/l NSE mean and 2.6 micrograms/l S-100 mean). Patients with bad outcome had an NSE concentration of 38 micrograms/l (mean) compared with 26.9 micrograms/l (mean) in patients with good outcome. Patients with bad outcome had an S-100 concentration of 4.9 micrograms/l (mean) compared with 1.7 micrograms/l (mean) in patients with good outcome (p < 0.05). The mean values of NSE and S-100 decreased during the first 5 days. Four patients with increasing intracranial pressure showed a quick increasing concentration of NSE, in two patients the S-100 level showed a slower rise. The NSE serum levels did not correlate with intracranial pressure values. Our results show that the first serum concentration of S-100 seems to be predictive for outcome after severe head injury.
Similar articles
- Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study.
Abboud T, Mende KC, Jung R, Czorlich P, Vettorazzi E, Priefler M, Kluge S, Westphal M, Regelsberger J. Abboud T, et al. World Neurosurg. 2017 Dec;108:669-675. doi: 10.1016/j.wneu.2017.09.074. Epub 2017 Sep 21. World Neurosurg. 2017. PMID: 28943424 - S-100B and neuron specific enolase in outcome prediction of severe head injury.
Li N, Shen JK, Zhao WG, Cai Y, Li YF, Zhan SK. Li N, et al. Chin J Traumatol. 2004 Jun;7(3):156-8. Chin J Traumatol. 2004. PMID: 15294113 - S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy.
Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen LO. Olivecrona M, et al. J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1241-7. doi: 10.1136/jnnp.2008.158196. Epub 2009 Jul 13. J Neurol Neurosurg Psychiatry. 2009. PMID: 19602473 Clinical Trial. - Correlation of computed tomography findings and serum brain damage markers following severe head injury.
Raabe A, Grolms C, Keller M, Döhnert J, Sorge O, Seifert V. Raabe A, et al. Acta Neurochir (Wien). 1998;140(8):787-91; discussion 791-2. doi: 10.1007/s007010050180. Acta Neurochir (Wien). 1998. PMID: 9810445 - Predictive Value and Correlation of Neuron-Specific Enolase for Prognosis in Patients with Coma: A Systematic Review and Meta-Analysis.
Ye W, Tang Y, Dong X, Chen G, Yan Y, Zhou L, Wang Z, Chen L, Li M, Feng Z. Ye W, et al. Eur Neurol. 2020;83(6):555-565. doi: 10.1159/000509801. Epub 2020 Oct 30. Eur Neurol. 2020. PMID: 33130683
Cited by
- S-100beta protein--serum levels in children with brain neoplasms and its potential as a tumor marker.
Rajendra A, Spinella PC, Drott HR, Dominguez TE, Sutton L, Helfaer M. Rajendra A, et al. J Neurooncol. 2004 May;67(3):345-9. doi: 10.1023/b:neon.0000024216.15923.77. J Neurooncol. 2004. PMID: 15164991 - Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.
Papa L, Robertson CS, Wang KK, Brophy GM, Hannay HJ, Heaton S, Schmalfuss I, Gabrielli A, Hayes RL, Robicsek SA. Papa L, et al. Neurocrit Care. 2015 Feb;22(1):52-64. doi: 10.1007/s12028-014-0028-2. Neurocrit Care. 2015. PMID: 25052159 - Early and persistent high level of PS 100β is associated with increased poor neurological outcome in patients with SAH: is there a PS 100β threshold for SAH prognosis?
Quintard H, Leduc S, Ferrari P, Petit I, Ichai C. Quintard H, et al. Crit Care. 2016 Feb 3;20:33. doi: 10.1186/s13054-016-1200-1. Crit Care. 2016. PMID: 26843206 Free PMC article. - Addressing the needs of traumatic brain injury with clinical proteomics.
Shen S, Loo RR, Wanner IB, Loo JA. Shen S, et al. Clin Proteomics. 2014 Mar 28;11(1):11. doi: 10.1186/1559-0275-11-11. Clin Proteomics. 2014. PMID: 24678615 Free PMC article. - Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.
Papa L, Lewis LM, Falk JL, Zhang Z, Silvestri S, Giordano P, Brophy GM, Demery JA, Dixit NK, Ferguson I, Liu MC, Mo J, Akinyi L, Schmid K, Mondello S, Robertson CS, Tortella FC, Hayes RL, Wang KK. Papa L, et al. Ann Emerg Med. 2012 Jun;59(6):471-83. doi: 10.1016/j.annemergmed.2011.08.021. Epub 2011 Nov 8. Ann Emerg Med. 2012. PMID: 22071014 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials